OSIVAX
  • COMPANY
    • ABOUT US
    • EXECUTIVE COMMITTEE
    • SCIENTIFIC ADVISORY BOARD
    • CLINICAL ADVISORY BOARD
    • BOARD OF DIRECTORS
    • PARTNERS
  • SCIENCE
  • PIPELINE
    • OVERVIEW
    • INFLUENZA - OVX836
    • CORONAVIRUS
  • NEWS
    • PRESS RELEASES
    • MEDIA COVERAGE
    • PUBLICATIONS
    • EVENTS
  • CONTACT
    • LEGAL MENTIONS

NEWS

PRESS RELEASE
publications
EVENTS


​MEDIA COVERAGE 

Companies to watch: Osivax​​
Published on October 1,  2020


Can Covid-19 Vaccines Keep up with an Evolving Virus?
​​
Published on August 27,  2020


Osivax secures $36M in grant, equity funding for flu, coronavirus vaccine programs
​​Published on July 8,  2020


French biotech gets funding for universal flu and coronavirus vaccines
​​
Published on July 9,  2020


Osivax Raises €32M to Develop Universal Coronavirus and Influenza Vaccines
​​
Published on July 8,  2020


French biotech Osivax nabs funding boost for universal flu, coronavirus vaccine work
​
Published on July 8,  2020


Scrip Informa Phama Intelligence - Osivax CEO Hopes Vaccines Maker Can Develop Universal Flu 'Silver Bullet'
Published on August 14, 2019


European Biotechnology -  €8M for universal flu vaccine​ ​
Published on July 11, 2019


Picture
Picture
Picture
Picture
Picture
Picture
Picture

RTBF - Une société biotech française séduite par Liège 
Published on July 11, 2019


BioWorld - Osivax advancing Universal flu vaccine with $9M  series A
Published on July 11, 2019


Picture
Picture

FierceBiotech - Osivax raises €8M for universal flu vaccine clinical trials 
Published
 on July 10, 2019

Picture

LABIOTECH.eu - French Startup's Universal Flu Vaccine Development Boosted by €8M  Series A
Published on July 10, 2019


Picture

EU-Startups - Lyon-based biotech startup Osivax raises €8 million in financing to develop novel, universal flu vaccines 
Published on July 10, 2019


Picture

FinSMEs - Osivax Raises €8M in Series A Funding 
Published on July 10, 2019


Picture

L'echo - Osivax s'installe à Liège pour y développer un vaccin universel contre la grippe 
​Published on July 10, 2019


Picture

Ccimag - Osivax lève 8 millions d’euros et planifie l’ouverture de bureaux à Liège 
Published on July 10, 2019


Picture

Siliconcanals - French biotech startup Osivax secures €8M to develop universal vaccine against influenza 
Published on July 10, 2019


Picture

LABIOTECH.eu - The Top 10 Biotechs You’ll Find in Lyon 
Published on July 10, 2019


Picture

LeProgres - Le vaccin contre la grippe d’Osivax pourrait générer plus d’un milliard par an 
Published on April 24, 2018


Picture

LABIOTECH.eu - This Newly Founded French Biotech is All About Vaccines
Published on June 23, 2017

Picture
Proudly powered by Weebly
  • COMPANY
    • ABOUT US
    • EXECUTIVE COMMITTEE
    • SCIENTIFIC ADVISORY BOARD
    • CLINICAL ADVISORY BOARD
    • BOARD OF DIRECTORS
    • PARTNERS
  • SCIENCE
  • PIPELINE
    • OVERVIEW
    • INFLUENZA - OVX836
    • CORONAVIRUS
  • NEWS
    • PRESS RELEASES
    • MEDIA COVERAGE
    • PUBLICATIONS
    • EVENTS
  • CONTACT
    • LEGAL MENTIONS